California State Teachers Retirement System Sells 1,167 Shares of Teleflex Incorporated (NYSE:TFX)

California State Teachers Retirement System reduced its position in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 1.7% in the first quarter, according to its most recent filing with the SEC. The fund owned 68,749 shares of the medical technology company’s stock after selling 1,167 shares during the quarter. California State Teachers Retirement System owned about 0.15% of Teleflex worth $15,549,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of TFX. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Teleflex during the 1st quarter valued at about $2,467,000. Victory Capital Management Inc. lifted its position in Teleflex by 47.8% in the fourth quarter. Victory Capital Management Inc. now owns 21,865 shares of the medical technology company’s stock worth $5,452,000 after buying an additional 7,070 shares during the last quarter. BNP Paribas Financial Markets raised its stake in shares of Teleflex by 35.5% in the fourth quarter. BNP Paribas Financial Markets now owns 39,735 shares of the medical technology company’s stock valued at $9,908,000 after acquiring an additional 10,405 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in shares of Teleflex by 243.6% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 22,722 shares of the medical technology company’s stock worth $5,666,000 after acquiring an additional 16,110 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Teleflex by 3.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 405,203 shares of the medical technology company’s stock worth $101,033,000 after purchasing an additional 12,150 shares during the period. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Trading Down 0.2 %

Shares of NYSE:TFX opened at $235.51 on Friday. The company has a market capitalization of $11.09 billion, a PE ratio of 37.89, a P/E/G ratio of 2.14 and a beta of 1.13. The company has a current ratio of 2.51, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 12-month low of $177.63 and a 12-month high of $257.85. The business’s fifty day simple moving average is $213.52 and its 200-day simple moving average is $221.54.

Teleflex (NYSE:TFXGet Free Report) last issued its quarterly earnings data on Thursday, August 1st. The medical technology company reported $3.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.33 by $0.09. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The firm had revenue of $749.70 million for the quarter, compared to the consensus estimate of $762.98 million. During the same quarter in the previous year, the firm earned $3.41 EPS. The company’s quarterly revenue was up .9% compared to the same quarter last year. As a group, equities research analysts predict that Teleflex Incorporated will post 13.75 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 16th. Stockholders of record on Thursday, August 15th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Thursday, August 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.58%. Teleflex’s dividend payout ratio is presently 21.83%.

Analysts Set New Price Targets

Several equities analysts have commented on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Friday, May 3rd. Truist Financial raised their price target on shares of Teleflex from $235.00 to $240.00 and gave the stock a “hold” rating in a research note on Tuesday, July 16th. Finally, Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and upped their target price for the stock from $205.00 to $245.00 in a research note on Monday, July 1st. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $263.14.

Get Our Latest Report on TFX

About Teleflex

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

See Also

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.